1,2-Diazole prevents cisplatin-induced nephrotoxicity in experimental rats

Pharmacological Reports

Volumn 65, Issue 4, 2013, Pages 980-990

  Prabhu, Venugopal Vinod ^a   Kannan, Narayanan ^a   Guruvayoorappan, Chandrasekharan ^a  

^a KARUNYA UNIVERSITY   (India)

Author keywords

1,2 diazole; Antioxidant; Cisplatin; Mangroves; Nephrotoxicity; Pyrazole; Renal disorder; Rhizophora apiculata

Indexed keywords

CATALASE; CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GUM ARABIC; LIPID PEROXIDE; PYRAZOLE; SILYMARIN; SUPEROXIDE DISMUTASE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY MASS; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; RENAL PROTECTION; SINGLE DRUG DOSE; UREA BLOOD LEVEL; URINE VOLUME;

ANIMALS; ANTIOXIDANTS; CISPLATIN; CREATININE; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PYRAZOLES; RATS; SILYMARIN; UREA; URINE;

EID: 84886553192     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(13)71079-X     Document Type: Article

References (38)

1. Aebi H.: Catalase. In: Methods in Enzymatic Analysis, Vol. 3. Ed. Bergmeyer HU, Academic Press, New York, 1983, 276-286.
2. Agogramoorthy G, Chem FA, Venkatesalu V, Kuo DH, Shea PC: Evaluation of anti-oxidant polyphenols from selected mangrove plants of India. Asian J Chem, 2008, 20, 1311-1322.
3. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol, 2003, 23, 460-464.
4. Beutler E, Kelly BM: The effect of sodium nitrite on red cell GSH. Experientia, 1963, 15, 96-97.
5. Behling EB, Sendao MC, Francescato HD, Antunes LM, Costa RS, Bianchi Mde L: Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep, 2006, 58, 526-532.
6. Bhat SG, Mishra S, Mei Y, Nie Z, Whitworth CA, Rybak LP, Ramkumar V: Cisplatin up-regulates The adenosine A1 receptor in The rat kidney. Eur J Pharmacol, 2002, 442, 251-264.
7. Chirino YI, Hernández-Pando R, Pedraza-Chaverrí J: Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol, 2004, 4, 20.
8. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol, 2009, 61, 223-242.
9. Dickey DT, Muldoon LL, Doolittle ND, Peterson DR, Kraemer DF, Neuwelt EA: Effect of N-Acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models. Cancer ChemoTher Pharmacol, 2008, 62, 235-241.
10. De Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P et al: Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy. Am J Physiol Renal Physiol, 2005, 289, F544-551
11. El-Shitany NA, El-Haggar S, El-desoky K: Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food Chem Toxicol, 2008, 46, 2422-2428.
12. Galea AM, Murray V: The interaction of cisplatin and analogues with DNA in reconstituted chromatin. Biochim Biophys Acta, 2002, 1579, 142-152.
13. Gautier JC, Riefke B, Walter J, Kurth P, Mylecraine L, Guilpin V, Barlow N et al.: Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with cisplatin. Toxicol Pathol, 2010, 38, 943-956.
14. Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg SS: The renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer, 1977, 39, 1362-1371.
15. Halliwell B, Chirico S: Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr, 1993, 57, 715S-724S.
16. Hanigan MH, Devarajan P: Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther, 2003, 1, 47-61.
17. Holland-Frei Cancer Medicine, 6th edn. Eds. Kufe DW, Pollock RE, Weichselbaum RR, Bast, Jr, RC, Gansler TS, James F Holland JF, Frei III E, BC Decker, Hamilton (ON), 2003.
18. Kakkar PS, Das B, Viswanathan PNA: Modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys, 1984, 21, 130-132.
19. Kohli HS, Bhaskaran MC, Muthukumar T: Treatmentrelated acute renal failure in The elderly: a hospital-based prospective study. Nephrol Dial Transplant, 2000, 15, 212-217.
20. Lau AH: Apoptosis induced by cisplatin nephrotoxic injury. Kidney Int, 1999, 56, 1295-1298.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with The Folin-phenol reagents. J Biol Chem, 1951, 193, 265-275.
22. Ma SF, Nishikawa M, Hyoudou K, Takahashi R, Ikemura M, Kobayashi Y, Yamashita F, Hashida M: Combining cisplatin with cationized catalase decreases nephrotoxicity while improving antitumor activity. Kidney Int, 2007, 72, 1474-1482.
23. Ognjanovic BI, Djordjevic NZ, Matic MM, Obradovic JM, Mladenovic JM, Stajn AS, Saicic ZS: Lipid peroxidative damage on cisplatin exposure and alterations in antioxidant defense system in rat kidneys: a possible protective effect of selenium. Int J Mol Sci, 2012, 13, 1790-1803.
24. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 1979, 95, 351-358.
25. Prabhu VV, Guruvayoorappan C: Anti-inflammatory and anti-tumor activity of The marine mangrove Rhizophora apiculata. J Immunotoxicol, 2012, 9, 341-352.
26. Prabhu VV, Kuruvilla CA, Guruvayoorappan C: Potentiating effect of 1,2-diazole a plant alkaloid on carrageenan and formalin induced paw edema in experimental mice. Int J Pharm Pharm Sci, 2012, 4, 3, 380-383 27. Rahim AA, Rocca E, Steinmetz J, Kassim MJ, Ibrahim MS, Osman H: Anti-oxidant activities of mangrove Rhizophora apiculata bark extracts. Food Chem, 2007, 107, 200-207.
27. Richter C, Gogvadze V, Laffranchi R, Schlapbach R, Schweizer M, Suter M, Walter P: Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta, 1995, 1271, 67-74.
28. Rotruck JT, Pope AL, GanTher HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science, 1973, 9, 588-590.
29. Schetz M, Dasta J, Goldstein S, Golper T: Drug-induced acute kidney injury. Curr Opin Crit Care, 2005, 11, 555-565.
30. Sener MT, Sener E, Tok A, Polat B, Cinar I, Polat H, Akcay F, Suleyman H: Biochemical and histologic study of lethal cisplatin nephrotoxicity prevention by mirtazapine. Pharmacol Rep, 2012, 64, 594-602.
31. Sindhu RK, Ehdaie A, Farmand F, Dhaliwal KK, Nguyen T, Zhan CD, Roberts CK, Vaziri ND: Expression of catalase and glutathione peroxidase in renal insufficiency. Biochim Biophys Acta, 2005, 1743, 86-92.
32. Stewart DJ, Mikhael NZ, Nanji AA, Nair RC, Kacew S, Howard K, Hirte W, Maroun JA: Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose, and nephrotoxicity. J Clin Oncol, 1985, 3, 1251-1256.
33. Sultana S, Verma K, Khan R: Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress. J Pharm Pharmacol, 2012, 64, 872-881.
34. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK: Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int, 2003, 63, 179-185.
35. Wild CP: The role of cancer research in non communicable disease control. J Natl Cancer Inst, 2012, 104, 1051-1058.
36. Wu G, Fang YZ, Yang S, Lupton JR, Turner ND: Glutathione metabolism and its implications for health. J Nutr, 2004, 134, 489.
37. Yao X. Panichpisal K, Kurtzman N, Nugent K: Cisplatin nephrotoxicity: a review: Am J Med Sci, 2007, 334, 115-124.
38. Zager RA: Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin Nephrol, 1997, 17, 3-14